The development of quality of life questionnaire of Chinese medicine for postoperative patients with colorectal cancer and item screening.
- Author:
Xiao-hua FAN
1
;
Hao WANG
;
Kang-lian TAN
;
Ai-hua OU
;
Ze-hui HE
;
Zhan-bin LUO
;
Si-fen ZHANG
;
Zhen-mu ZHENG
;
Jin-bin YAO
;
Li ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Colorectal Neoplasms; surgery; Humans; Medicine, Chinese Traditional; methods; Postoperative Period; Quality of Life; Surveys and Questionnaires; Treatment Outcome
- From: Chinese Journal of Integrated Traditional and Western Medicine 2013;33(3):307-313
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo develop quality of life questionnaire of Chinese medicine for postoperative patients with colorectal cancer (QLQ-CMPPCC), thus comprehensively and objectively evaluating the clinical efficacy of Chinese medicine and pharmacy in treating postoperative patients with colorectal cancer (CC).
METHODSThe theoretical structure model of the questionnaire was addressed in combined with basic theories of Chinese medicine according to the principle of WHO quality of life (QOL). The primary questionnaire was developed using methods of structuralization policy making after we extensively retrieve various universal and specific questionnaires for CC cancer patients at home and abroad. The 205 CC patients were tested by questionnaire. The items were screened using experts grading method, item selection analysis, dispersion trends of standard deviation, t-test, correlation coefficient method, factor analysis,and Cronbach's alpha.
RESULTSThe QLQ-CMPPCC was developed containing four domains of physical, psychological, independence, and social functions, involving 20 aspects and 54 items. Of them, non-fistula patients answered 43 items and fistula patients answered 46 items. One item covered the general QOL evaluation.
CONCLUSIONSQLQ-CMPPCC showed Chinese medical features. It comprehensively reflected the connotation of QOL for postoperative CC patients. It could be taken as a tool for evaluating Chinese medical efficacy for postoperative CC patients.